Hyaline Globules in Neuroendocrine and Solid-pseudopapillary Neoplasms of the Pancreas
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 35 (7) , 981-988
Abstract
Distinguishing between solid-pseudopapillary neoplasms (SPNs) and pancreatic neuroendocrine tumors (PanNETs) may pose a diagnostic dilemma. Both can demonstrate solid growth patterns, and both can be immunoreactive with neuroendocrine markers such as synaptophysin and CD56. One well-established feature of SPNs is the presence of hyaline globules, which in contrast has only rarely been reported in PanNETs. Clinicopathologic features of 361 cases originally classified as PanNETs were examined. Of these, 24 tumors (6.6%) had hyaline globules, raising the possibility of SPN. Immunohistochemistry for β-catenin was performed on these 24 neoplasms, and showed nuclear labeling in 6 cases. These 6 cases, which also demonstrated cytoplasmic CD10 staining, were reclassified as SPNs. The remaining 18 cases maintained their original diagnosis as PanNETs, and the hyaline globules in these cases were periodic acid-Schiff (PAS) positive, diastase resistant, and immunoreactive with α-1-antitrypsin. All 24 cases were histologically re-evaluated, and the pattern of invasion, presence of clear cells, and nuclear grooves were found to be helpful in distinguishing SPNs from PanNETs. We conclude that the presence of hyaline globules should raise SPNs in the differential diagnosis of a solid cellular neoplasm of the pancreas. However, this should not be used as the sole criterion in the diagnosis of SPNs, as hyaline globules may also be seen in 5% of PanNETs. Immunohistochemical and histologic features supporting the diagnosis of SPNs over PanNETs include CD10 and nuclear β-catenin labeling, an insidious pattern of invasion, clear cells, and nuclear grooves.Keywords
This publication has 56 references indexed in Scilit:
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomasCancer Treatment Reviews, 2010
- Intraductal oncocytic papillary carcinoma of the pancreas showing numerous hyaline globules in the lumenPathology International, 2009
- Radiotherapy for Pancreatic Neuroendocrine TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreasBritish Journal of Surgery, 2008
- Clinical Comparison of Distal Pancreatectomy with or without SplenectomyJournal of Korean Medical Science, 2008
- Nonductal neoplasms of the pancreasLaboratory Investigation, 2007
- Non‐cystic solid‐pseudopapillary tumor of the pancreas showing nuclear accumulation and activating gene mutation of β‐cateninPathology International, 2006
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Malignant potential of solid pseudopapillary neoplasm of the pancreasBritish Journal of Surgery, 2006